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Summary 
Pluripotent cells develop within the inner cell mass of blastocysts, a mosaic of 
cells surrounded by an extra-embryonic layer, the trophectoderm. We show that a set 
of somatic lineage regulators (including Hox, Gata and Sox factors) that carry bivalent 
chromatin enriched in H3K27me3 and H3K4me2 are selectively targeted by 
Suv39h1-mediated H3K9me3 and de novo DNA methylation in extra-embryonic 
versus embryonic (pluripotent) lineages, as assessed both in blastocyst-derived stem 
cells and in vivo. This stably repressed state is linked with a loss of gene priming for 
transcription through exclusion of PRC1 (Ring1B) and RNA Polymerase II 
complexes at bivalent, lineage-inappropriate genes upon trophoblast lineage 
commitment. Collectively, our results suggest a mutually exclusive role for Ring1B 
and Suv39h1 in regulating distinct chromatin states at key developmental genes and 
propose a novel mechanism by which lineage specification can be reinforced during 
early development. 
 
Introduction 
Gene expression programmes must be tightly controlled to govern cell identity 
and lineage choice. An inherent challenge for developing organisms is to maintain a 
critical balance between stable and flexible gene regulation (Reik, 2007). This is most 
obvious in pluripotent embryonic stem (ES) cells, which are functionally 
characterized by their ability to self-renew and to generate all somatic lineages when 
induced. Accordingly, ES cells express genes that encode self-renewal factors, while 
repressing many lineage-specific regulators that are ultimately required during 
development (Jaenisch and Young, 2008). A series of recent reports have indicated 
how Polycomb-mediated gene repression might provide short-term, and therefore 
flexible, epigenetic silencing of such developmental genes in pluripotent cell lines 
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(Azuara et al., 2006; Bernstein et al., 2006a; Boyer et al., 2006; Lee et al., 2006; Pan 
et al., 2007; Zhao et al., 2007). This contrasts with long-term repression mechanisms 
as conferred, for example, by DNA methylation at transposons, imprinted and 
pluripotency-associated genes in somatic cells (Bird, 2002; Delaval and Feil, 2004; 
Epsztejn-Litman et al., 2008; Farthing et al., 2008; Weber and Schubeler, 2007). 
Two distinct Polycomb Repressive Complexes (PRC), PRC1 and PRC2, are 
known to be important for the function of ES cells. PRC2 contains Ezh2, which 
catalyzes histone H3 lysine 27 tri-methylation (H3K27me3), as well as Eed and 
Suz12. PRC1 contains the E3 ubiquitin ligases Ring1A and Ring1B that mono-
ubiquitinylate histone H2A lysine 119. Other PRC1 components include Bmi1, Mel18 
and proteins of the Cbx family with H3K27 methylation affinity (Bantignies and 
Cavalli, 2006; Pietersen and van Lohuizen, 2008; Ringrose and Paro, 2007; 
Schuettengruber et al., 2007; Schwartz and Pirrotta, 2007; Simon and Kingston, 
2009). Candidate-based (Azuara et al., 2006) and genome-wide (Bernstein et al., 
2006a) studies of histone methylation in ES cells led to the remarkable finding that 
many PRC2-target genes carry not only the repressive H3K27me3 mark, but are also 
enriched for conventional indicators of active chromatin, including methylated H3K4. 
These so-called bivalent chromatin domains are thought to silence key developmental 
regulators while keeping them primed for future activation (or repression) and thus 
generally resolve to monovalent configurations upon differentiation in accordance 
with gene expression changes (Bernstein et al., 2006a; Mikkelsen et al., 2007; Pan et 
al., 2007). Further work showed that multipotent stem cells and some differentiated 
cells also possess bivalent domains, albeit perhaps fewer than in ES cells (Barski et 
al., 2007; Bernstein et al., 2006a; Bracken et al., 2006; Cui et al., 2009; Mikkelsen et 
al., 2007; Pan et al., 2007; Roh et al., 2006; Sanz et al., 2008; Wei et al., 2009), 
indicating that plasticity may be maintained at loci that are required for the function 
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and differentiation of lineage-committed cells. Consistent with gene priming, bivalent 
genes assemble RNA polymerase II complexes preferentially phosphorylated on Ser-5 
residues (poised RNAP) and are transcribed at low levels (Brookes and Pombo, 2009; 
Guenther et al., 2007; Stock et al., 2007). Productive expression is, however, 
prevented by the action of PRC1 with conditional deletion of Ring1A/B resulting in 
an up-regulation of target gene expression in ES cells (from primed to overt 
transcription) (Endoh et al., 2008; Guenther et al., 2007; Jorgensen et al., 2006; Stock 
et al., 2007).  
Clearly, Polycomb repressors are functionally required to prevent premature 
expression of primed genes and thus stably maintain a pluripotent ES cell identity in 
culture (Azuara et al., 2006; Boyer et al., 2006; Chamberlain et al., 2008; Endoh et al., 
2008; Leeb and Wutz, 2007; van der Stoop et al., 2008). Whether ES cell epigenetic 
signatures can also be seen in the developing embryo and when (and how) bivalent 
domains are established and subsequently resolved upon lineage commitment in vivo 
remains to be elucidated. In this study, we have focused on the earliest stages of 
mouse development to address whether poised chromatin structures are unique 
hallmarks of the founder (pluripotent) cells of the early embryo and investigate the 
kinetics of appearance and resolution of bivalent domains during the first lineage 
decision event (trophectoderm formation). We provide in vivo evidence that bivalent 
histone marking operates in the early mouse embryo from the 8-cell up to the 
blastocyst stage. Unexpectedly, we show that bivalent domains are retained at a subset 
of genes encoding key somatic lineage regulators in extra-embryonic restricted cells, 
as assessed both in vitro and in vivo. However, and in contrast to pluripotent cells, 
PRC1 (Ring1B) and poised RNAP are not engaged at these PRC2 (Suz12)-bound 
genes, consistent with a loss of gene priming. Instead, bivalent genes become 
selectively targeted by Suv39h1-mediated repression upon trophoblast lineage 
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commitment. Collectively, our results suggest a mutually exclusive role for Ring1B 
and Suv39h1 in specifying the fate of bivalent genes in a lineage-specific manner 
upon blastocyst formation.  
  
Materials and methods 
Cell lines 
B1-TS cell line was established and maintained as described (Mak et al., 2004). 
ZHBTc4-ES cells were cultured on gelatinised plates with LIF 1000U/µl (ESGRO-
LIF; Millipore) (Azuara et al., 2006). Pou5f1 repression in ZHBTc4 was induced by 
addition of doxycycline (Sigma) at 1μg/ml. TS-like (TSL) cells were derived from 
Dox-treated ZHBTc4-ES cells plated at low density on irradiated feeders in the 
presence of 37ng/ml FGF4 (R&D Systems) and 1μg/ml heparin (Sigma) (Niwa et al., 
2000). Note that Dox treatment was sustained for approximately two weeks in these 
conditions; time at which positive staining for the trophectoderm stem cell marker 
Cdx2 was seen in the same proportion of ZHBTc4 - derived TSL cells as B1-TS cells, 
while Oct4 was undetectable in either culture. TSL cells could then be serially 
passaged and propagated in culture for at least 6 weeks.    
RNA Interference 
Lentivirus vector containing short-hairpin RNA (shRNA) targeting mouse Suv39h1 
mRNA was cloned in pLKO.1 (Sigma). The sequence used to successfully 
knockdown expression of Suv39h1 target is as follows: 5’-
GCCTTTGTACTCAGGAAAG-3’ (TRCN97439). Recombinant lentiviruses were 
generated using a three-plasmid system in 293 T cells as previously described (Kutner 
et al., 2009). Virus containing culture supernatants were collected after 24 and 48 
hours of transfection, pooled, concentrated and used for infection. Control and 
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Suv39h1 knockdown TS cells were collected at 5 days post infection for subsequent 
expression and chromatin analysis.  
Embryo collection and dissection 
Pre-pubescent CBAB6 F1 females were super-ovulated by intrauterine injections of 
PMSG (5U Folligon®; Intervet, UK) followed 42 hours later by HCG (5U 
Chorulon®; Intervet, UK) and mating overnight with CBAB6 F1 males. At 2.5 days 
post-coitum compacted morula were flushed from the oviduct in EmbryoMax® M-2 
(Millipore), snap frozen or cultured overnight up to the blastocyst stage in 30μl 
droplets of equilibrated EmbryoMax® M-16 (Millipore) under mineral oil. Early-
stage blastocysts were selected based on morphology; TE samples were acquired 
using Leica manual manipulators and micro-dissection blades (Bioniche) on a Nikon 
Diaphot with DIC optics as previously described (O'Neill et al., 2006). Individual 
ICMs were isolated by immunosurgery on a Nikon SMZ dissection microscope, using 
rabbit anti-mouse serum, guinea-pig complement and acidified Tyrode’s solutions 
(Sigma) (Solter and Knowles, 1975). 8-cell embryos were collected at 2 days post-
coitum and snap frozen for subsequent expression and chromatin analyses. 
Antibodies 
Antibodies used were as follows. For ChIP: anti-H3 (ab1791; Abcam), anti-H3K4me2 
(07–030; Millipore), anti-H3K4me3 (ab8580; Abcam), anti-H3K27me3 (07–449; 
Millipore), anti-H3K9me3 (07-442; Millipore), anti-IgG (20259; Dako), anti-Ring1B 
(a kind gift from H. Koseki) (Atsuta et al., 2001), anti-Suz12 (Pab-029-050; 
Diagenode); anti-Suv39h1 (Abcam; ab12405); anti-hypo-phosphorylated (8WG16; 
Covance) and anti-Ser5-phosphorylated RBP1 CTD (4H8; Millipore) (Stock et al., 
2007). For MeDIP: anti-5mC (BI-MECY-1000; Eurogentec). For western blotting: 
anti-Suz12 (07-379; Millipore), anti-Ring1B (Atsuta et al., 2001), anti-tubulin 
(ab6046; Abcam) and anti-mouse or anti-rabbit-HRP (Santa Cruz). For 
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immunofluorescence: anti-Suz12 (07-379; Millipore), anti-Ring1B (Atsuta et al., 
2001), anti-mouse IgG or anti-rabbit IgG conjugated with Alexa Fluor® 488/568 
(Molecular probes).  
Epigenetic profiling analysis 
Histone ChIP on cross-linked chromatin from cells (Azuara et al., 2006) and 
sequential ChIP (Bernstein et al., 2006a); histone ChIP on native chromatin from 
tissues (Sanz et al., 2008); RNAP, PRC1 and PRC2 ChIP (Stock et al., 2007) and 
methylated DNA immunoprecipitation (MeDIP) analysis (Mohn et al., 2008) were 
carried out as previously described. Carrier ChIP, followed by quantitative PCR 
(qPCR) was performed as described with minor modifications (O'Neill et al., 2006). 
S2 Drosophila cells (5 x 107 cells/ml) were mixed with; 8-cell (40n), compacted 
morula (20n), ICM or TE (10-12n) per immunoprecipitation. Native chromatin 
fragments were prepared by digestion with 5U of micrococcal nuclease (GE 
Healthcare) per 2.5µg of chromatin and subsequently incubated with 15µl of 
commercially available antibodies against modified histones or control IgG 
antibodies. Protein A sepharose (GE healthcare) was added to immobilize chromatin-
antibody complexes; unbound chromatin fractions were recovered upon centrifugation 
and bound complexes further washed in a series of stringent buffers. Elution was 
carried in 1% SDS prior to proteinase K 0.2mg/ml (Sigma) treatment of both unbound 
and bound fractions. DNA was subsequently purified on gel extraction columns 
(Qiagen) into a final volume of 50-60µl TE buffer. DNA concentrations were 
determined by PicoGreen fluorimetry (Invitrogen) and unbound fractions diluted to 
match bound concentrations, before qPCR analysis using mouse-specific primers. 
Real-time qPCR analysis was carried out on a Chromo4 DNA engine (Biorad, 
Hercules, CA), using SYBR green jumpstart PCR master mix (Sigma) and 300nM 
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primers. Each qPCR reaction was performed in triplicate. Primer sequences are 
available on request. 
Expression analysis  
Total RNA was isolated using the RNeasy Mini (cell line samples) or Micro (embryo 
samples) kits and DNase I treatment (Qiagen). Samples were reverse transcribed 
using Superscript II following manufacturer’s recommendations (Invitrogen) and 
analysed by qPCR. Primer sequences are available on request. 
Western blot analysis 
Protein concentrations of whole cell extracts were measured using the Bradford assay 
(Thermo Fisher Scientific). 20µg samples were loaded onto 10% acrylamide gels and 
blotted onto methanol activated polyvinylidene fluoride membranes using a semi-dry 
transfer system. After incubation and washing, membranes were treated with 
enhanced chemiluminescent substrate (Thermo Fisher Scientific).  
Immunofluorescence analysis 
Cells were seeded on gelatinised glass coverslips and fixed in PBS with 4% 
paraformaldehyde. Samples were permeabilised and blocked at room temperature 
before incubation with antibodies. Coverslips were mounted on Vectashield with 
DAPI (Vector labs) and examined using a Leica SP5 confocal microscope (x40 or x63 
lenses). 
 
Results 
Bivalent domains mark silent, lineage-inappropriate genes in trophoblast stem cells. 
In pre-implantation development the transition from morula to blastocyst is the 
starting point for lineage segregation into the inner cell mass (ICM) and 
trophectoderm (TE) (Fig. 1A). ES cells are derived from the ICM and are pluripotent. 
In contrast, TE-restricted trophoblast stem (TS) cells are multipotent and contribute 
 9
solely to placenta formation in vivo (Rossant and Tam, 2009). To investigate whether 
bivalent signatures are unique attributes of pluripotent cells in the early embryo, we 
directly compared the chromatin environment of key developmental genes in ES and 
TS cells. In particular, we focused on previously identified bivalent, CpG-rich 
promoters in ES cells (Azuara et al., 2006; Bernstein et al., 2006a; Mikkelsen et al., 
2007) that were described as PRC2 and PRC1 joint targets (Fig. 1; Ku et al., 2008). 
We have included in this study a panel of transcriptional regulators (Atoh1, Gata4, 
Hoxa7, Kdr, Mixl1, Pax3, Sox1 and Sox7) covering different embryonic lineages, as 
well as TS-associated markers (Cdx2, Fgfr2 and Hand1). Note that genetic 
inactivation of most of these genes results in embryonic lethality (Table S1).  
Chromatin immunoprecipitation (ChIP) and quantitative PCR (qPCR) were 
performed to initially evaluate the abundance of repressive H3K27me3 and 
permissive H3K4me2 histone marks at selected promoters in ES and TS cells (Fig. 
1B). For these analyses, qPCR primers were designed to amplify up to 600bp 
upstream of each gene’s transcriptional start site. Modified histone levels were 
normalised against detected H3, and expressed as relative enrichment (% over H3). 
As anticipated, significant enrichment for H3K27me3 and H3K4me2 marks was 
detected at the promoters of silent genes in ES cells (Fig. 1B; left panel). Actively 
transcribed Actin shows, in contrast, low H3K27me3 and high H3K4me2 levels while 
an intergenic region used as negative control is not enriched for either histone 
modification. In TS cells, all silent promoters analysed (including Atoh1, Sox1, 
Hoxa7, Mixl1, Gata4 and Sox7) also showed high levels of H3K27me3 together with 
H3K4me2, suggesting these genes remain bivalent despite the fact that none of them 
are normally expressed upon placental development (Fig. S1). In contrast, the active 
Cdx2, Fgfr2, Hand1, Kdr and Pax3 promoters were only marked by H3K4me2 in TS 
cells, as expected (Fig. 1B; right panel).  
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The retention of bivalent domains in trophoblast-restricted cells at genes that are 
not required in this lineage was unexpected. To verify that methylated H3K27 and 
H3K4 co-exist on the same allele in TS cells, we performed a series of sequential 
ChIP experiments where chromatin was firstly immunoprecipitated with H3K27me3 
and secondly with H3K4me2 antibodies (Fig. 1C) and vice versa (data not shown). 
Results confirmed that all genes with bivalent domains were simultaneously enriched 
for both marks in TS cells as well as in ES cells in comparison with expressed genes 
and controls. Remarkably, substantial enrichment for both H3K4me2 and H3K4me3 
was still detected at bivalently marked genes when TS cells were induced to 
differentiate into spongiotrophoblasts and trophoblast giant cells, even though none of 
these genes are activated (Fig. S2). Taken together, these data show that restriction of 
developmental potency in TE-derived stem cells and differentiated progeny is not 
necessarily accompanied by a loss of activating marks at silent, lineage-inappropriate 
genes.  
 
Bivalent histone marking operates in vivo at silent genes in the early mouse 
embryo.  
To address whether bivalent domains are also present in vivo, we examined the 
histone profile of key developmental genes in the ICM and TE of newly formed 
blastocysts as well as in early 8-cell and morula-stage embryos. Individual ICMs were 
isolated by immunosurgery of early-stage blastocysts while mural TE samples were 
prepared by manual dissection (Fig. 2A). Typically, 10-12 ICM or TE preparations 
were combined per immunoprecipitation. 8-cell embryos (40n) and compacted morula 
(20n) were freshly collected and pooled for subsequent analyses. Histone 
modifications were analysed using carrier ChIP (C-ChIP) followed by qPCR (O'Neill 
et al., 2006; VerMilyea et al., 2009). C-ChIP allows small pools of ex vivo 
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populations to be analysed by mixing with excess carrier Drosophila S2 cells, before 
preparation of nuclei and chromatin (see protocol outlined in Fig. 2B). Using this 
approach, we assessed the relative enrichment for H3K27me3 and H3K4me2 at the 
promoters of Sox1 and Gata4 – two examples of bivalently marked genes in both ES 
and TS cells, as well as Pou5f1 and Cdx2, which show differential gene expression 
patterns upon pre-implantation development (Dietrich and Hiiragi, 2007; Jedrusik et 
al., 2008). Pou5f1 transcripts were detected in 8-cell and morula embryos and 
remained present in both ICM and TE tissues of newly formed blastocysts whereas 
Cdx2 was predominantly expressed in the TE, as expected (Fig. S3).  
Sox1 and Gata4 were undetectable in 8-cell embryos onwards (Fig. S3). In 
agreement with the lack of expression, these promoters displayed high levels of the 
repressive H3K27me3 marks in all four populations analysed, in contrast to actively 
transcribed Pou5f1, which shows low H3K27me3 and high H3K4me2 levels (Fig. 
2C). H3K4me2 was also detected alongside H3K27me3 at Sox1 and Gata4, 
demonstrating the occurrence of bivalent domains in vivo. These domains were seen 
from the 8-cell embryo up to the blastocyst stage at silent loci, suggesting that they 
are established early during pre-implantation development and stably retained upon 
blastocyst formation in both ICM and TE lineages. Cdx2 showed, in contrast, a more 
dynamic histone profile being enriched for both marks in early 8-cell embryos and 
ICM cells where this gene is expressed at low or variable levels, but depleted of 
H3K27me3 marks in TE-committed cells (Fig. 2C; bottom panel). Together, these 
results corroborate our in vitro data in ES and TS cells and further reveal that bivalent 
histone signatures associated with gene silencing exist in the early mouse embryo, 
prior to blastocyst formation and during the blastocyst stage. 
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Ring1B and poised RNAP are not recruited to genes that retain bivalent signatures 
in TE-derived stem cells. 
 To further explore the chromatin status of bivalent, lineage-inappropriate genes 
in trophoblast committed cells, we assessed the patterns of PRC2 and PRC1 binding 
at selected promoters in TS cells as compared to ES cells. As anticipated from the 
presence of H3K27me3, the PRC2 component Suz12 was found at all bivalent 
promoters analysed in both populations, although relatively lower levels were seen in 
TS cells (Fig. 1D). However, in striking contrast to ES cells, silent, Suz12-bound 
genes showed only low (or undetectable) enrichment for the PRC1 component 
Ring1B in TS cells, as seen at their active counterparts. These altered profiles of 
Suz12 and Ring1B binding did not correlate with global changes in protein levels in 
the two cell types (Fig. 1E). The presence of Ring1B proteins in TS cells was also 
verified by immunofluorescence, confirming the co-localisation of Ring1B and Suz12 
components on the inactive X chromosome of female trophoblast stem cells, as 
expected (Fig. 1F; de Napoles et al., 2004; Fang et al., 2004).  
PRC1 and RNAP act together in ES cells to maintain a poised chromatin state at 
bivalent genes. To investigate whether bivalently marked genes in TS cells are also 
primed by RNAP, we next examined the recruitment and conformation of these 
complexes by ChIP assay using previously validated antibodies against hypo-
phosphorylated (8WG16) or Ser5-phosphorylated (Ser5P; 4H8) RNAP (Stock et al., 
2007). As shown in Fig. 3, bivalent genes and active (Actin and Hprt) controls were 
found highly enriched for Ser5P RNAP at their promoter regions in ES cells. A poised 
RNAP conformation was discriminated by measuring the level of 8WG16 binding, 
which was low at bivalent promoters but abundant at actively transcribed controls, as 
reported (Guenther et al., 2007; Stock et al., 2007). In TS cells, Ser5P and 8WG16 
RNAP both marked expressed Cdx2, Fgfr2, Hand1, Kdr and Pax3 genes and active 
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controls, as expected (Fig. 3; right panel). RNAP complexes were, in contrast, 
virtually absent from the promoters of Atoh1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7, 
consistent with a loss of gene priming for transcription at these loci in TS cells.  
 
Selective induction of the H3K9 tri-methyltransferase Suv39h1 upon trophoblast 
lineage commitment.  
The loss of Ring1B and RNAP recruitment at bivalently marked promoters in TS 
cells as compared to ES cells suggests that alternative repressive pathways may 
operate to regulate these loci in extra-embryonic and embryonic tissues. To further 
investigate the relationship between lineage identity and targeted chromatin changes, 
we exploited the potential to convert ES cells into TS-like cells, using a previously 
established ES cell line that carries a Doxycycline (Dox) regulated Pou5f1 transgene 
(ZHBTc4; Niwa et al., 2000) (Fig. 4A). In this system, Dox-treated ES cell colonies 
gradually acquire a TS-like (TSL) morphology upon Pou5f1 shutdown and provision 
of permissive conditions (Fig. 4B), while established TSL cell cultures show uniform 
staining for the TE-associated marker Cdx2, as seen in TS cells (Fig. 4C). Here, we 
surveyed by qRT-PCR the relative mRNA levels for a cohort of chromatin regulators, 
including PRC components, histone lysine methylases (KMTs) and demethylases 
(KDMs) as well as DNA methyltransferases (DNMTs) in ES and TS cells, and looked 
at dynamic gene expression alterations upon Pou5f1 shutdown and TSL cell 
derivation (Fig. 4D).  
In agreement with previous reports (Mak et al., 2004; Matoba et al., 2006), we 
verified that Eed expression is rapidly and significantly reduced, in contrast to its 
partners, Ezh2 and Suz12, in Dox-treated ES, TSL and TS cells as compared to ES 
cells. Surprisingly, we identified a pronounced imbalance in mRNA levels for several 
H3K9 KMTs (Ehmt1, G9a, Suv39h1 and Suv39h2) and H3K9 KDMs (Jmjd1a and 
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Jmjd2c) between ES and TS cell populations. In particular, H3K9 tri/di-demethylase 
Jmjd2c (Cloos et al., 2006; Wissmann et al., 2007), which is highly expressed in 
undifferentiated ES cells (Loh et al., 2008) was promptly down-regulated upon 
Pou5f1 shutdown (Fig. 4E). Conversely, H3K9 tri-methyltransferase Suv39h1 was 
dramatically up-regulated upon TSL cell derivation and Cdx2 induction with a 30-fold 
increase in TSL and TS cells relative to ES cells (Fig. 4E). By comparison, Suv39h2, 
G9a or Ehmt1 showed a relatively modest induction (from 4 to 6-fold) upon ES cell 
differentiation, while Eset (also known as Setdb1) remained expressed at similar 
levels in all populations analysed (Fig. 4E; bottom panel). These results point to a key 
role for Suv39h1 in the establishment or maintenance of a TSL cell fate; an 
observation consistent with the selective induction of Suv39h1 (in contrast to 
Suv39h2, G9a, Ehmt1 or Eset) in TE relative to ICM or morula cells in vivo (Fig. 4F). 
 
H3K9 tri-methylation specifies epigenetic asymmetry at bivalent genes between 
ICM and TE lineages. 
To address whether Suv39h1 could directly target bivalent genes upon 
trophoblast lineage commitment and assess its functional implication, we compared 
the levels of Suv39h1 occupancy, H3K9 tri-methylation and associated DNA 
methylation (Fuks et al., 2003) at the same panel of developmental regulators and 
control (Actin and γ-satellite) loci in ES, Dox-treated ES (ESDox48h), TSL and TS 
cells (Fig. 5 and S4). As anticipated, Cdx2, Fgfr2, Hand1, Flk1 and Pax3 expression 
was up-regulated to levels seen in TS cells upon Dox treatment and TSL cell 
derivation (Fig. S5). Thus, little H3K9me3 (Fig. 5A) or DNA methylation (Fig. 5B) 
associated with gene silencing was detected at these induced promoters that were 
marked by H3K4me2 only in TSL cells, as previously seen in TS cells (Fig. S4). In 
contrast, Atoh1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 genes remained inactive (Fig. 
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S5) and bivalently marked (Fig. S4) in Dox-treated ES and TSL cells. These genes, 
however, become selectively targeted by Suv39h1 and rapidly acquired substantial 
levels of H3K9me3 upon loss of pluripotency and trophoblast lineage commitment 
(Fig. 5A and S4). Conversely, Suv39h1 knockdown by RNAi in TS cells (Fig. 5C) led 
to a reduction of H3K9me3 levels at bivalently marked genes, confirming Suv39h1-
dependent H3K9 methylation (Fig. 5D and Fig. S6). This establishes an unusual 
trivalent (H3K9me3-H3K27me3-H3K4me2) histone profile at silent, lineage-
inappropriate genes in TS cells, as further verified by sequential ChIP assays (Fig. 
5E). Interestingly, PRC1 (Ring1B) together with Ser5P RNAP forms were transiently 
retained at un-induced loci as opposed to activated genes in Dox-treated ES cells, yet 
released in TSL and TS cells, suggesting that loss of gene priming and acquisition of 
Suv39h1-mediated H3K9me3 at bivalent genes are likely to be coordinated (Fig. S4). 
Note, however, that Suv39h1 is not required to prevent transcriptional activation of 
Atoh1, Sox1, Hoxa7, Mixl1, Gata4 and Sox7 in Dox-treated ES cells (data not shown) 
or TS cells (Fig. S6) but might rather stabilize a repressed state at silent, bivalent 
genes in synergy with other epigenetic marks including H3K27me3. Consistently, 
chromatin changes from primed to repressed states at Suv39h1-bound genes were 
reinforced by de novo DNA methylation associated with stable silencing (Lande-
Diner and Cedar, 2005) in TSL and TS cells in the absence of Ring1B (Fig. 5B and 
S4).  
To further verify that bivalent, lineage-inappropriate genes are selectively 
targeted by Suv39h1-mediated H3K9 methylation upon TE formation in vivo, we 
examined the levels of H3K9me3 at Sox1, Gata4 and Cdx2 promoters prior (morula) 
and after (ICM and TE) blastocyst formation, by C-ChIP and qPCR (Fig. 5F). The 
results showed Sox1 and Gata4 genes harboured high levels of H3K9me3 in addition 
to H3K27me3 and H3K4me2 in the TE but not in the ICM; an epigenetic signature 
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also maintained in the developing placenta in vivo (data not shown). Moreover, 
H3K9me3 levels were low in compacted morula, further suggesting that the 
acquisition of the repressive H3K9me3 marks might be a late event linked with 
trophoblast cell fate consolidation and loss of lineage plasticity. In contrast, actively 
transcribed Cdx2 remained depleted of H3K9me3 in the TE, as expected (Fig. 5F; 
bottom panel). Together, our results indicate that alternative silencing strategies 
operate in a lineage-specific manner at key developmental regulators in the early 
embryo. 
 
Discussion 
In eukaryotes, H3K9 tri-methyltransferases Suv39h1 and Suv39h2 are commonly 
associated with constitutive heterochromatin formation and function. In the zygote, 
however, paternal constitutive heterochromatin lacks Suv39h-mediated H3K9me3, 
and is instead targeted by PRC1 components including Ring1B (Arney et al., 2002; 
Probst et al., 2007; Puschendorf et al., 2008; Santos et al., 2005). This differential 
loading of Ring1B and Suv39h onto heterochromatin underlies parental genome 
asymmetry in the zygote and is subsequently maintained through cell divisions up to 
the 8-cell stage (Puschendorf et al., 2008). In this study, we find that Ring1B and 
Suv39h1 selectively target key developmental genes in a lineage-specific manner at 
the blastocyst stage, suggesting that Ring1B/Suv39h mutual exclusion may occur 
throughout pre-implantation development.  
In particular, we propose that PRC1 (Ring1B) and poised RNAP – two hallmarks 
of gene priming in pluripotent cells, are dynamically removed from the promoters of 
bivalent genes upon TE cell fate acquisition and Suv39h1 recruitment (see model in 
Fig. 6). In this model, H3K9me3 and downstream repressive activities (e.g. DNA 
methylation) would reinforce the repressed state of Suv39h1-bound genes upon loss 
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of Ring1B. Absence of Ring1B enrichment at these loci does not, however, exclude 
the possible recruitment of other PRC1-like complexes in TE-restricted cells as 
compared to pluripotent cells, owing to the dynamic composition of Polycomb 
complexes during development (Otte and Kwaks, 2003; Schuettengruber and Cavalli, 
2009). This is exemplified by the reverse expression pattern of Phc1 and Phc2 in ES 
and TS cells (Fig. 4D) and differential recruitment of these proteins on the inactive X 
chromosome in the two cell types (de Napoles et al., 2004). The distribution and 
density of methylated H3K27 and H3K9 marks in the vicinity of bivalent promoters 
could also alter the affinity of Cbx members as previously suggested (Bernstein et al., 
2006b).  
 An important aspect of our findings is the addition of the key repressive marks, 
H3K9me3 alongside DNA hypermethylation at promoters that retain high levels of 
methylated H3K4; an epigenetic state also reported in embryonic carcinoma cells 
(Ohm et al., 2007).  This contrasts with prevailing views that loss of H3K4 
methylation is a prerequisite for ‘locking-in’ a repressed state at bivalent genes that 
are not activated upon differentiation (Bernstein et al., 2006a; Meissner et al., 2008; 
Mohn et al., 2008). Our study reveals a novel mechanism by which ‘bivalency’ (and 
gene priming) can be resolved in extra-embryonic restricted cells through Suv39h1 
recruitment and formation of a trivalent (H3K9me3-H3K27me3-H3K4me2) histone 
conformation at silent, somatic-associated genes. Interestingly, trivalent histone 
configurations were recently uncovered using a genome-wide approach at a limited 
set of genes encoding trophoblast and early differentiation markers in ES cells 
(Bilodeau et al., 2009; Yuan et al., 2009). This indicates that ‘trivalency’ may not be 
particular to the trophoblast lineage. In pluripotent cells, however, many of these 
genes are occupied by a different member of the H3K9 KMT family, Eset, 
highlighting the distinct roles and/or target specificity of these chromatin regulators in 
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early development and stem cells. Whether Ring1B and poised RNAP are also 
excluded from Eset-bound promoters remains to be elucidated however. 
   Importantly, we provide in vivo evidence that bivalent chromatin domains exist 
at silent developmental regulators in the early mouse embryo. These domains are 
present in 8-cell embryos and persist throughout pre-implantation development, 
providing a platform for further protein recruitment that would, in turn, dictate the 
fate of bivalent genes (repressed versus primed) upon lineage commitment. While 
trophoblast lineage ‘fixation’ is shown to involve Suv39h1 recruitment at bivalent, 
lineage-inappropriate genes, it is equally possible that transcriptional priming and 
pluripotency is retained through active protection from H3K9 and/or DNA 
methylation. Interestingly, and in keeping with this idea, Suv39h1 and Jmjd2c, which 
mediate H3K9 tri-methylation and demethylation respectively, display dynamic and 
opposite gene expression patterns in vivo. While Jmjd2c is highly expressed in early 
cleavage-stage embryos (Wang et al., 2009), Suv39h1 mRNA levels gradually 
increase during pre-implantation development with a peak at the transition from 
morula to blastocyst (Puschendorf et al., 2008). In our study, these two epigenetic 
factors are also shown to be differentially expressed in blastocyst-derived stem cells 
(Fig. 4D). As previously reported, Jmjd2c is instrumental in stably maintaining ES 
cell identity in vitro (Loh et al., 2008). Similarly, we find that RNAi depletion of 
Suv39h1 in TS cells causes a loss of TS cell markers (Cdx2, Eomes, Fgfr2 and Gata3) 
and induction of differentiation-associated markers (Pl1 and Tpbpa), suggesting that 
Suv39h1 may also be required for TS cell self-renewal (Fig. S7).  
 In summary, we show that Ring1B and Suv39h1 delineate distinct chromatin 
states at bivalent genes in a lineage-specific manner during early mouse lineage 
commitment. A key function for Ring1B in the epigenetic gene regulation of early 
embryos is consistent with the embryonic lethality of Ring1B-mutant mice (Voncken 
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et al., 2003). In contrast, Suv39h1/h2 mutant mice show a relatively mild phenotype, 
most likely reflecting the synergy of repressive marks (Peters et al., 2001). A possible 
role for Suv39h1 at early-stages of development is, however, strongly supported by its 
selective induction (in contrast to other H3K9 KMTs) in the newly formed 
trophectoderm. To address whether Ring1B loss and/or Suv39h function directly 
impacts on early cell fate decisions will require further in vivo lineage-tracing 
investigations. 
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Figure Legends 
Figure 1. Comparison of epigenetic features in blastocyst-derived stem cells. 
(A) Schematic representation of morula and blastocyst embryos, depicting lineage 
segregation of inner cell mass (ICM) and trophectoderm (TE). ES and TS cells can be 
derived from the ICM and TE, respectively. (B) Relative enrichment of H3K27me3 
and H3K4me2 at a panel of selected promoters and controls in ZHBTc4-ES (green 
bars) and B1-TS (orange bars) cells. Background levels (from control IgG antibodies) 
are shown as grey bars. (C) Sequential ChIP using anti-H3K27me3 and anti-
H3K4me2 antibodies. Enrichment is expressed relative to H3. (D) Binding of PRC2 
and PRC1 components Suz12 and Ring1B, respectively was assessed by ChIP and 
qPCR. Enrichment is expressed relative to input. Error bars represent s.d. of 3 
independent experiments. (E) Western blot analysis using anti-Suz12, anti-Ring1B 
and anti-tubulin (loading control) antibodies. (F) Immunofluorescence analysis in 
female B1-TS cells, showing co-localisation of Suz12 and Ring1B on inactive X 
chromosomes (white arrows); scale bar represents 10μm.  
Figure 2. In vivo analysis of bivalent domains at selected promoters in early 
mouse embryos prior and after blastocyst lineage segregation.  
(A) Typical early-stage blastocyst selected for these experiments. ICM samples were 
isolated by immunosurgery based on selective, complement-induced lysis of 
trophoblast cells, which can then be washed away to leave a relatively pure ICM 
preparation. Mural TE samples were prepared by manual dissection; blastocysts were 
retained by a holding pipette and part of TE cut away to ensure no contamination with 
ICM. (B) A diagrammatic summary of the carrier ChIP (C-ChiP) protocol. (C) 
Quantification by C-ChIP of H3K27me3 and H3K4me2 levels (bound/unbound 
ratios) at the promoters of Sox1, Gata4, Pou5f1 and Cdx2 in 8-cell (light grey), 
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compacted morula (grey), ICM (green) and TE (orange). Antibody-bound and 
unbound chromatin fractions were amplified in parallel by qPCR using the same 
quantity of DNA. Unspecific precipitation was monitored by control IgG antibodies, 
showing background levels as denoted by dotted lines. Error bars represent s.d. of 3 
independent experiments. 
Figure 3. RNA Polymerase II occupancy and conformation at bivalent genes in 
ES and TS cells.  
Abundance of Ser5-phosphorylated (Ser5P) or hypo-phosphorylated (8WG16) RNAP 
at bivalent, active promoters and intergenic control in ZHBTc4-ES (green bars) and 
B1-TS (orange bars) cells. Background levels (from control antibodies) are shown as 
grey bars. Enrichment was assessed by ChIP and qPCR and is expressed relative to 
input. Error bars represent s.d. of 3 independent experiments. 
Figure 4. Developmentally-regulated changes in gene expression profiles of 
chromatin regulators upon Pou5f1 repression and TS-like cell derivation.  
(A) Schematic representation of Pou5f1 shutdown and Cdx2 activation induced upon 
Doxycyline (Dox) treatment of ZHBTc4-ES cells. Differentiation into TS-like (TSL) 
cells was accomplished by culture on inactivated primary embryonic fibroblasts and 
in the presence of FGF4 and heparin. (B) Light microscope images comparing the 
morphology of ZHBTc4-derived TS-like (TSL) and B1-TS (TS) colonies. (C) 
Immunofluorescence analysis showing homogenous expression of the TS-associated 
marker, Cdx2 in TSL and TS cells. Note that no Cdx2 signal was detected in untreated 
ZHBTc4-ES cells, as expected (data not shown). (D) The expression of selected 
chromatin regulators was compared in ZHBTc4-ES cells after 24 and 48 hours of Dox 
treatment (ESDox) in the presence of LIF; ZHBTc4-derived TSL (TSL) cells and B1-
TS (TS) cells using quantitative RT-PCR (qRT-PCR). Values shown are normalised 
to Actin and L19 and expressed relative to untreated ZHBTc4-ES cells (ES=1). Up-
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regulation (mean +/- s.d. > 2) and down-regulation (mean +/- s.d. < 0.5) are coloured 
in red and blue, respectively. (E) Histograms showing the expression pattern of Cdx2, 
Pou5f1, Suv39h1, Jmjd2c, Suv39h2, Ehmt1, G9a and Eset upon Pou5f1 shutdown and 
TSL cell derivation. Error bars represent s.d. of 3 independent experiments. (F) 
Expression levels of Cdx2, Suv39h1, Suv39h2 and G9a as assessed by qRT-PCR in 
morula (grey), dissected ICM (green) and TE (orange) sample preparations. Values 
shown are normalised to S17 and L19 mRNA levels and expressed relative to morula 
samples (morula = 1). Error bars represent s.d. of 3 independent experiments. Note 
that Ehmt1 and Eset transcript levels were below detection in all three samples under 
the same experimental conditions (data not shown). N.D; not detectable. 
Figure 5. Bivalent genes are targeted by Suv39h1-mediated H3K9me3 upon 
trophectoderm lineage commitment in vitro and in vivo. 
The abundance of H3K9me3 and Suv39h1 was assessed by ChIP (A) and DNA 
methylation (5mC) by MeDIP (B) at candidate gene promoters and controls in 
ZHBTc4-ES cells (green; ES), ZHBTc4-derived TS-like (light orange; TSL) and B1-
TS (orange; TS) cells. Background levels (from control antibodies) are shown as grey 
bars. Genes that remain inactive and bivalently marked in TSL and TS cells are 
highlighted. Enrichment is expressed relative to H3 or input. Error bars represent s.d. 
of 3 independent experiments. (C) Expression levels of Suv39h1 and Suv39h2 as 
assessed by qRT-PCR in TS cells after knockdown using Suv39h1 shRNA construct. 
Values shown are normalised to S17 and L19 mRNA levels and expressed relative to 
control TS cells. Error bars represent s.d. of 3 independent experiments. (D) 
Quantification by C-ChIP and qPCR of H3K9me3 levels at the promoters of Sox1, 
Gata4 and Sox7 in Suv39h1 knockdown TS cells relative to control cells after 
normalising against their respective unbound fractions and IgG controls. Error bars 
represent s.d. of 3 independent experiments. (E) Sequential ChIP using anti-
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H3K9me3 and anti-H3K27me3 (upper panel) or anti-H3K9me3 and anti-H3K4me2 
(bottom panel) antibodies in B1-TS cells. Enrichment is expressed relative to H3. 
Error bars represent s.d. of 3 independent experiments. (F) Quantification by C-ChIP 
and qPCR of H3K9me3 levels at the promoters of Sox1, Gata4 and Cdx2 in 
compacted morula (grey), ICM (green) and TE (orange). Unspecific precipitation was 
monitored by control IgG antibodies, showing background levels as denoted by dotted 
lines. Error bars represent s.d. of 3 independent experiments.  
Figure 6. Model for the establishment of distinct chromatin states at bivalent 
genes in vivo upon blastocyst lineage segregation. 
RNA Polymerase II (RNAP) and Ring1B (PRC1) depletion at Suz12 (PRC2)-bound 
bivalent (H3K4me2 and H3K27me3) loci is associated with acquisition of an extra-
embryonic fate and transcriptional repression by Suv39h1-mediated H3K9me3 and 
DNA methylation (5mC). 
 
Supplemental Figure Legends 
Supplemental Figure 1.  Gene expression of candidate genes in the placenta.  
RNA levels of candidate genes were measured by qRT-PCR in placenta at 12.5 days 
post-coitum. Data were normalised to housekeeping genes (Actin and L19) and 
expressed relative to control tissues: TS cells (Cdx2, Fgfr2, Hand1 and Kdr), heart 
(Pax3), intestine (Atoh1), embryonic E15 head (Sox1), kidney (Hoxa7), embryoid 
bodies (Mixl1) and XEN cells (Gata4 and Sox7). Brackets demarcate silent 
developmental genes that retain bivalent chromatin domains in TS cells. Error bars 
represent s.d. of 3 independent experiments. Similar results were obtained using late 
gestation placenta (data not shown). These data demonstrate that genes co-occupied 
by H3K27me3 and H3K4me2 in TS cells (Atoh1, Sox1, Hoxa7, Mixl1, Gata4 and 
Sox7) are not activated upon placental development. 
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Supplemental Figure 2. Differentiated TS cells harbour H3K4me2 and 
H3K4me3 at lineage-inappropriate genes.  
TS cell differentiation was induced by FGF4, heparin and primary embryonic 
fibroblast conditioned media withdrawal over four days. (A) mRNA levels of TS cell 
associated genes (Cdx2 and Fgfr2) and differentiation markers (Tpbpa and Pl1) were 
measured by qRT-PCR before (TS; white bars) and after (TSdiff.; black bars) 
differentiation. Data were normalised to housekeeping genes (Actin and L19) and 
expressed relative to undifferentiated TS cells (TS = 1). (B) Light microscope images 
show TS cells under maintenance growth conditions (TS) and after four days of 
differentiation (TSdiff.).  (C) The relative enrichment of H3K4me2 and H3K4me3 was 
assessed at selected loci by ChIP and qPCR in TSdiff. cells.  Actin and an intergenic 
region are used as positive and negative controls, respectively.  Background levels 
(from control IgG antibodies) are shown as grey bars. Error bars represent s.d. of 2 
independent experiments. These data show that Atoh1, Sox1, Hoxa7, Mixl1, Gata4 
and Sox7 that are not activated upon TS cell differentiation retained substantial levels 
of methylated H3K4 at their promoter regions.  
Supplemental Figure 3. Expression levels of candidate loci prior and after 
blastocyst lineage segregation.  
Expression levels of Pou5f1, Cdx2, Sox1 and Gata4 as assessed by qRT-PCR during 
one typical series of 8-cell (light grey), morula (grey), dissected ICM (green) and TE 
(orange) sample preparation. Values shown are normalised to S17 and L19 mRNA 
levels. N.D;  not detectable. 
Supplemental Figure 4. Targeted chromatin changes at key developmental genes 
in ES cells upon Pou5f1 repression and trophoblast lineage commitment. 
ChIP analysis of ZHBTc4-ES cells after 0 (ES) and 48 hours (ESDox48h) of 
Doxycyline (Dox) treatment to induce Pou5f1 repression; ZHBTc4-derived TS-like 
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(TSL) and B1-TS (TS) cells at candidate gene promoters and controls. Error bars 
represent s.d. of 3 independent experiments. Brackets demarcate silent developmental 
genes that retain bivalent chromatin domains in TSL and TS cells. Asterisks indicate 
the use of alternative positive control (γ-satellite) for H3K9me3 ChIP and 5mC 
MeDiP analysis. 
Supplemental Figure 5. Kinetics of candidate gene expression in ZHBTc4-ES 
cells following Pou5f1 shutdown and subsequent TS-like cell derivation. 
 Expression levels of selected genes were assessed by qRT-PCR in ZHBTc4-ES cells 
after 0 (white), 24 (light grey) and 48 hours (dark grey) of Doxycyline (Dox) 
treatment to induce Pou5f1 repression; ZHBTc4-derived TS-like (light black) and B1-
TS (black) cells. Brackets demarcate silent developmental genes that retain bivalent 
chromatin domains in TSL and TS cells. Data were normalised to housekeeping genes 
(Actin and L19) and expressed relative to untreated ZHBTc4-ES cells (ES = 1). Error 
bars represent s.d. of 3 independent experiments.  
Supplemental Figure 6. Suv39h1 regulates H3K9 methylation at bivalent, 
lineage-inappropriate genes in TS cells. 
(A) Expression levels of Suv39h1, Suv39h2, Ehmt1, G9a and Eset were assessed by 
qRT-PCR in Suv39h1 shRNA lentivirus infected TS cells as compared to control TS 
cells. Error bars represent s.d. of 3 independent experiments. (B) Quantification by C-
ChIP and qPCR of H3K4me2 (green), H3K27me3 (blue), H3K9me3 (red) levels at 
Sox1, Gata4 and Sox7 promoters in Suv39h1 lentivirus infected TS cells relative to 
control cells (white) after normalising against their respective unbound fractions and 
IgG controls. Error bars represent s.d. of 3 (H3K4me2 and H3K9me3) or 2 
(H3K27me3) independent experiments.  
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Supplemental Figure 7. Knockdown of Suv39h1 in TS cells.  
(A) TS cell markers Cdx2, Eomes, Fgfr2 and Gata3 were reduced, while the 
differentiation markers Tpbpa and Pl1 were induced in Suv39h1 shRNA lentivirus 
infected TS cells as compared to control TS cells. Error bars represent s.d. of 3 
independent experiments. (B) Immunofluorescence staining of TS cells with anti-
Cdx2 antibody, showing a loss of Cdx2 expression in trophoblast cells upon Suv39h1 
depletion (white arrows). Scale bar represents 10 μm.  
 
 
 
 






